Hypertension, An Issue of Medical Clinics of North America (Volume 101-1) (The Clinics: Internal Medicine, Volume 101-1)
Description:
This issue of Medical Clinics, guest edited by Dr. Edward Frohlich, is devoted to Hypertension. Articles in this outstanding issue include The Kidney in Hypertension; Heart: Fibrosis, Apoptosis, and Cardiac Failure; Myocardial Ischemia; Oxidative Stress and Hypertensive Diseases; Adherence to Antihypertensive Therapy; Aging and Hypertension; Target Organs and Microbiological Considerations in Hypertensive Diseases; Obesity and Sodium Considerations; Diabetes, Hypertension and Cardiorenal Syndrome; Renal Arterial Disease; Cardiac Transplantation and Hypertensive Diseases; Cardiac Failure: Old and New Challenges; Diastolic Dysfunction and Hypertension; Stiffening of Large Arteries; Genetics and Mechanisms; New Guidelines for Hypertensive Diseases; and Local Renin Angiotensin Systems.
Best prices to buy, sell, or rent ISBN 9780323482639
Frequently Asked Questions about Hypertension, An Issue of Medical Clinics of North America (Volume 101-1) (The Clinics: Internal Medicine, Volume 101-1)
The price for the book starts from $11.60 on Amazon and is available from 6 sellers at the moment.
If you’re interested in selling back the Hypertension, An Issue of Medical Clinics of North America (Volume 101-1) (The Clinics: Internal Medicine, Volume 101-1) book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.
As for the Hypertension, An Issue of Medical Clinics of North America (Volume 101-1) (The Clinics: Internal Medicine, Volume 101-1) book, the best buyback offer comes from and is $ for the book in good condition.
The Hypertension, An Issue of Medical Clinics of North America (Volume 101-1) (The Clinics: Internal Medicine, Volume 101-1) book is in very low demand now as the rank for the book is 8,706,894 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.
Not enough insights yet.